PHI with Generalized scleroderma
How does this condition affect your private health insurance?
Generalized scleroderma, also known as systemic sclerosis, is a chronic, rare autoimmune disease characterized by the hardening and tightening of the skin and connective tissues, as well as progressive damage to internal organs like the lungs, heart, kidneys, and gastrointestinal tract. It results from an overproduction of collagen and an abnormal immune response. Symptoms range from Raynaud's phenomenon and skin thickening to severe organ dysfunction, such as pulmonary fibrosis, cardiac issues, or renal crisis. The disease course is highly variable and progressive, significantly impacting life quality and requiring lifelong, complex management.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several months to a few years, as initial symptoms may develop slowly before diagnosis.
Duration of Illness (Lifetime)
Chronic, lifelong disease requiring continuous medical management.
Cost of Treatment (Initial)
High, encompassing extensive diagnostic work-up, specialist visits, and initial medications; can range from several thousands to tens of thousands of dollars.
Cost of Treatment (Lifetime)
Very high, due to ongoing medication, frequent specialist visits, management of complications, and potential hospitalizations; often hundreds of thousands of dollars or more.
Mortality Rate
Significant, particularly with severe organ involvement (e.g., pulmonary hypertension, renal crisis, severe cardiac involvement), varying widely depending on disease subtype and organ damage.
Risk of Secondary Damages
Very high, as systemic sclerosis inherently causes progressive fibrosis and damage to various internal organs (lungs, heart, kidneys, GI tract, musculoskeletal system) leading to significant secondary complications.
Probability of Full Recovery
Extremely low; systemic sclerosis is a chronic, progressive disease with no known cure. Treatment focuses on managing symptoms, slowing disease progression, and preventing complications, rather than achieving complete recovery.
Underlying Disease Risk
Moderate to high, as systemic sclerosis can overlap with other autoimmune diseases (e.g., Sjögren's syndrome, rheumatoid arthritis) or increase the risk of developing certain other conditions due to chronic inflammation and organ damage.